Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 1.73 CAD
Market Cap: 79.5m CAD
Have any thoughts about
Theratechnologies Inc?
Write Note

Theratechnologies Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theratechnologies Inc
Cost of Revenue Peer Comparison

Comparables:
B
DRUG
RPTX
AUPH
COV
EDT

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Theratechnologies Inc
TSX:TH
Cost of Revenue
-$19.4m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
-21%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cost of Revenue
-$28.1m
CAGR 3-Years
-258%
CAGR 5-Years
N/A
CAGR 10-Years
-98%
Covalon Technologies Ltd
XTSX:COV
Cost of Revenue
-CA$12.7m
CAGR 3-Years
9%
CAGR 5-Years
-1%
CAGR 10-Years
-18%
Spectral Medical Inc
TSX:EDT
Cost of Revenue
-CA$1.2m
CAGR 3-Years
-22%
CAGR 5-Years
-14%
CAGR 10-Years
-5%

See Also

What is Theratechnologies Inc's Cost of Revenue?
Cost of Revenue
-19.4m USD

Based on the financial report for Aug 31, 2024, Theratechnologies Inc's Cost of Revenue amounts to -19.4m USD.

What is Theratechnologies Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-21%

Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Theratechnologies Inc have been 7% over the past three years , 4% over the past five years , and -21% over the past ten years .

Back to Top